Inventor · disambiguated record
Kevin W. Gillman
Also filed as: GILLMAN KEVIN · GILLMAN KEVIN W
21 granted patents·2 pending applications·74 citations·filing 1999–2022
93Inventor score
Top patents by PatentIndex Score
23 records- 0193US9856292B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·12 cites·32 claims
- 0290US10633419B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·7 cites·4 claims
- 0387US11358988B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 14, 2022·2 cites·8 claims
- 0484US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 0584US8084477B2Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide productionSTARRETT JR JOHN E·Filed 2008·Granted Dec 27, 2011·7 cites·4 claims
- 0682US11066445B2Immunomodulators acting as antagonists of PD-1BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·2 cites·6 claims
- 0778US11952434B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 9, 2024·0 cites·6 claims
- 0877US10988507B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 27, 2021·2 cites·9 claims
- 0971US8691821B2Oxazolidinones as modulators of mGluR5DEGNAN ANDREW P·Filed 2011·Granted Apr 8, 2014·3 cites·14 claims
- 1069US8093276B2Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide productionSTARRETT JR JOHN E·Filed 2009·Granted Jan 10, 2012·0 cites·4 claims
- 1169US8044077B2Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Oct 25, 2011·1 cites·8 claims
- 1268USRE49735EOxazolidinones as modulators of MGLUR5BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 28, 2023·0 cites·16 claims
- 1361US8383821B2NK-1 and serotonin transporter inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 26, 2013·0 cites·9 claims
- 1460US6930100B2Phosphate prodrugs of fluoroxindolesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 16, 2005·2 cites·10 claims
- 1560US6096745AImidazolone anorectic agents: III. heteroaryl derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Aug 1, 2000·12 cites·7 claims
- 1658US6054590AImidazolone anorectic agents: II. phenyl derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Apr 25, 2000·14 cites·9 claims
- 1754US8350084B2Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide productionBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 8, 2013·0 cites·1 claims
- 1853US2007249607A1Nk-1 and serotonin transporter inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1947US6916937B2Carbohydrate prodrugs of fluorooxindolesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 12, 2005·0 cites·8 claims
- 2043US7091202B24-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 15, 2006·0 cites·10 claims
- 2142US2008027056A1Substituted heterocyclic ethers and their use in cns disordersBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2241US8071778B2Substituted heterocyclic ethers and their use in CNS disordersPARKER MICHAEL F·Filed 2008·Granted Dec 6, 2011·0 cites·10 claims
- 2339US6063934AImidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-diphenyl-4H-imidazol-4-onesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted May 16, 2000·2 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Kevin W. Gillman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →